Yinhuang decoction alleviates RSV-induced viral pneumonia via TLR4/NF-κB/NLRP3 pathway with colloidal phase as dominant active fractions

Puntos clave

• Yinhuang decoction significantly reduces symptoms of viral pneumonia, highlighting its therapeutic effect.
• Key measurements included reduction in inflammatory markers related to the TLR4/NF-κB/NLRP3 pathway.
• Analysis of the biological response demonstrated protective effects when using Yinhuang decoction in respiratory conditions.
• Further investigations might reveal the specific active fractions involved, signaling a need for detailed exploration.